ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. Ann Surg 2002 Nov;236(5):694; author reply 694-6
Date
11/01/2002Pubmed ID
12409677Pubmed Central ID
PMC1422632DOI
10.1097/01.SLA.0000037256.09376.FCScopus ID
2-s2.0-0036835591 (requires institutional sign-in at Scopus site) 28 CitationsAuthor List
Evans DB, Hess KR, Pisters PWAuthor
Douglas B. Evans MD Chair, Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdenocarcinomaChemotherapy, Adjuvant
Humans
Pancreatectomy
Pancreatic Neoplasms
Survival Rate
